Tag archive for ‘Biogen Idec Inc. (Nasdaq: BIIB)’
CFO Eyal Desheh, TEVA
Adi Ben-Israel On Thursday, October 31st, 2013

Teva Acting CEO Eyal Desheh: Teva Has 13 New Therapeutic Entities Waiting For Approval

– Acting CEO Eyal Desheh / Getty – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) acting CEO Eyal Desheh today said that Copaxone continued to lead in new prescriptions for multiple More...

Wordpress site Developed by Fixing WordPress Problems